Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

423 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional Registry.
de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Daamen LA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Philippens MEP, Sahgal A, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Tseng CL, Hall WA, Verkooijen HM; MR-Linac Consortium. de Mol van Otterloo SR, et al. Among authors: harrington kj. Int J Radiat Oncol Biol Phys. 2021 Nov 15;111(4):867-875. doi: 10.1016/j.ijrobp.2021.07.003. Epub 2021 Jul 13. Int J Radiat Oncol Biol Phys. 2021. PMID: 34265394 Free PMC article.
A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading.
Khalid U, McGough C, Hackett C, Blake P, Harrington KJ, Khoo VS, Tait D, Norman AR, Andreyev HJ. Khalid U, et al. Among authors: harrington kj. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1432-41. doi: 10.1016/j.ijrobp.2005.10.007. Int J Radiat Oncol Biol Phys. 2006. PMID: 16580497
Novel targeted radiosensitisers in cancer treatment.
Zaidi SH, Huddart RA, Harrington KJ. Zaidi SH, et al. Among authors: harrington kj. Curr Drug Discov Technol. 2009 Jun;6(2):103-34. doi: 10.2174/157016309788488348. Curr Drug Discov Technol. 2009. PMID: 19519337 Review.
Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study.
Bhide SA, Davies M, Burke K, McNair HA, Hansen V, Barbachano Y, El-Hariry IA, Newbold K, Harrington KJ, Nutting CM. Bhide SA, et al. Among authors: harrington kj. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1360-8. doi: 10.1016/j.ijrobp.2009.04.005. Int J Radiat Oncol Biol Phys. 2010. PMID: 20338474
Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers.
Miah AB, Bhide SA, Guerrero-Urbano MT, Clark C, Bidmead AM, St Rose S, Barbachano Y, A'hern R, Tanay M, Hickey J, Nicol R, Newbold KL, Harrington KJ, Nutting CM. Miah AB, et al. Among authors: harrington kj. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):539-47. doi: 10.1016/j.ijrobp.2010.09.055. Epub 2011 Jan 13. Int J Radiat Oncol Biol Phys. 2012. PMID: 21236602 Clinical Trial.
423 results